Company Profile: Elevance Health, Inc. (ELV)

ELV insider trades (13 months) →

$413.75 +0.04% vs. previous close · Market cap $89.73B

Today's multi-factor rank: 50 of 461 · see the ranking

Quant500 Scores

Momentum

5.7/10

Value

7.1/10

Growth

4.9/10

Quality

5.0/10

Multifactor

5.7/10

Market and Valuation

Price & Market

Prev Close Price:$413.60

Open:$412.82

Day's Low:$411.47

Day's High:$417.39

Bid / Ask:-

Market Cap:89.73B

Enterprise Value:82.38B

52-Week Range

52-Week Low:$274.84

52-Week High:$450.69

Current position in 52-week range

52w Low-52w High

50-Day Avg:$410.82

200-Day Avg:$372.51

Volume

Volume Today:917,299

Avg Volume (3m):1,179,973

Avg Volume (10d):1,529,250

52-Week Change:+30.63%

vs S&P 500, 52 weeks:-

Beta:0.63

Valuation Multiples

P/E (trailing):17.59

Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 21, 2026. The P/E is the price divided by that EPS.

P/E (forward):13.66

PEG Ratio:1.27

Price / Book:2.00

Price / Sales (TTM):0.44

EV / Revenue:0.41

EV / EBITDA:9.46

Dividends

Current yield:1.66%

Annual Dividend Rate:$6.88

Dividend Trailing:$6.87

Yield Trailing:1.66%

5-Year Avg Yield:1.31%

Payout Ratio:29.17%

Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-

Fiscal Year (Next):-

Date Filter (Month):

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):201.83B

Gross Profit:53.35B

EBITDA:8.71B

Net Income (TTM):5.14B

Rev Growth (YoY):+1.40%

Earnings Growth (YoY):+17.90%

Quarterly earnings growth (YoY):+14.80%

Margins

Gross Margin:-

EBITDA Margin:-

Operating Margin:-

Net Margin:-

Per Share

EPS Trailing (TTM):$23.52

Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 21, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$30.29

Revenue Per Share:$923.29

Cash Per Share:-

Book Value:$206.75

Last Dividend:-

Ex-Dividend Date:-

Last Split:-

Balance Sheet & Liquidity

Total cash:37.85B

Total Debt:30.76B

Net Debt (Debt - Cash):−7.09B (net cash)

Debt / Equity:68.66%

Current Ratio:1.47

Quick Ratio:1.34

Cash Flows

Operating Cash Flow:7.60B

Free Cash Flow (FCF):7.99B

FCF Yield (FCF / Market Cap):-

Enterprise Value:82.38B

EV / Revenue:0.41

EV / EBITDA:9.46

Profitability

ROE (Return on Equity):11.48%

ROA (Return on Assets):4.01%

P/E (trailing):17.59

P/E (forward):13.66

Price / Book:2.00

PEG Ratio:1.27

52-Week Change:+30.63%

S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$23.52

Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 21, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$30.29

P/E (forward):13.66

PEG Ratio:1.27

Growth and Margins

Earnings Growth YoY:-

Quarterly Earnings Growth YoY:-

Rev Growth YoY:-

Net Margin:-

Gross Margin:-

EBITDA Margin:-

Per Share

Revenue Per Share:$923.29

Cash Per Share:-

Book Value:$206.75

Cash Flows (TTM)

Free Cash Flow:7.99B

Operating Cash Flow:7.60B

EBITDA:8.71B

Total Revenue (TTM):201.83B

Net Income (TTM):5.14B

Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter	Period	Actual EPS	Estimated EPS	Difference	Surprise %	Currency

Ownership Structure

Ownership Distribution

% Insiders:-

% Institutional:-

% Inst. (of Float):-

No. of Institutions:-

Visual distribution

InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:216,869,290

Float (free shares):215,569,765

Short interest (shares):5,137,559

Short % of float:-

Short Ratio (days to cover):4.04

Short interest, prior month:-

Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-

Audit Risk:-

Board risk:-

Compensation Risk:-

Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization	Report Date	% Shares	No. Shares	Value (USD)	Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund	Report Date	% Shares	No. Shares	Value (USD)	Change %

Recent Insider Trades

Executive / Insider	Title	Date	Action	Shares

Options Chain

Expiration Date:

CALLS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

PUTS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

Elevance Health, Inc. (ELV) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type	Date	Official link
S-3ASR	2026-10-28	View filing ↗
10-Q	2026-10-21	View filing ↗
8-K	2026-09-10	View filing ↗
8-K	2026-07-15	View filing ↗
11-K	2026-06-17	View filing ↗
8-K	2026-06-10	View filing ↗
8-K	2026-05-13	View filing ↗
8-K	2026-04-22	View filing ↗
DEFA14A	2026-03-27	View filing ↗
8-K	2026-03-10	View filing ↗

Company and Executive Profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

General Information

Headquarters:United States

City:Indianapolis

Employees:96,129

Sector:Healthcare

Industry:Healthcare Plans

Website:-

Key Executives

Name	Title	Age	Total pay
Ms. Gail Koziara Boudreaux	President, CEO & Director	64	4.94M
Mr. Mark Bradley Kaye	Executive VP & CFO	45	2.01M
Mr. Peter David Haytaian Esq.	Special Advisor	55	2.06M
Mr. Charles Morgan Kendrick Jr.	EVP and President of Commercial & Specialty Health Benefits	59	1.91M
Ms. Felicia Farr Norwood	Executive VP & Chief Health Benefits Officer	65	2.03M
Mr. Scott Wayne Anglin	SVP, Treasurer & Chief Investment Officer	-	-
Mr. Ronald William Penczek	Senior VP, Controller & Chief Accounting Officer	60	-
Mr. Nathan Allen Rich	Vice President of Investor Relations	-	-

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

Elevance Health, Inc. (ELV): Quantitative Analysis

Name: Factor scores for Elevance Health, Inc. (ELV)
Creator: Quant500
License: https://quant500.com/legal

Elevance Health, Inc. (ELV) — Healthcare — Healthcare Plans. ELV is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, ELV has returned +19.5% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.

ELV ranks 50 of 461 on today's multifactor score, and 4 of the 55 Healthcare companies that score. Its strongest factor is value (Z 1.28, ranked 26 of 489); its weakest is growth (Z -0.09, ranked 207 of 489). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

Factor	Z-Score	Rank
Multifactor	0.396	50 of 461
Momentum	0.391	143 of 494 ↑18
Value	1.276	26 of 489 ↑1
Quality	0.005	207 of 468
Growth	-0.087	207 of 489

Market data

Metric	Value
Price	$413.75
Market Cap	89.73B
P/E	17.59
Revenue (last 12 months)	201.83B
Price / book	2.00
Book value per share	$206.75
52-week range	$274.84 – $450.69
Dividend yield	1.66%
Beta	0.63
Average volume	1,179,973
Shares outstanding	216.87M
Short interest (% of float)	2.65% (as of Oct 15, 2026)

When does ELV report earnings? 12 of its last 12, before the open →

What are ELV insiders doing? 57 transactions filed with the SEC, of them 3 buys and 6 sells, the last one on Oct 22, 2026 →

ELV latest SEC filings

Annual report (10-K): filed Feb 6, 2026, fiscal year ended Dec 31, 2025 · view the filing on sec.gov
Quarterly report (10-Q): filed Oct 21, 2026 · view the filing on sec.gov
Earnings release (8-K): Oct 21, 2026, before the open · view the 8-K on sec.gov

Filing dates on EDGAR, the SEC's public registry. All ELV filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about Elevance Health (ELV)

When does Elevance Health report earnings?

Elevance Health has no announced date in the Nasdaq public calendar checked (Nov 3, 2026 to Dec 7, 2026). Of its last 12 earnings announcements: 12 before the open (SEC filings through Oct 21, 2026). ELV earnings dates and times, quarter by quarter →

What is Elevance Health's P/E ratio?

Elevance Health's P/E (price over earnings per share for the last twelve months) is 17.6 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Sep 30, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Elevance Health is below its sector median. Healthcare stocks, company by company →

Where does Elevance Health rank on Quant500?

In the Nov 3, 2026 multi-factor ranking, Elevance Health ranks 50 of 461, and 4 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking → How it is calculated →

Have Elevance Health insiders bought or sold shares?

The latest open-market purchase of Elevance Health shares filed with the SEC (Form 4) was on Jul 17, 2026, by a director who is also an officer, for $1.0M. The latest sale was on Oct 22, 2026, by an officer, for $4.7M. In total, from August 2025 through Nov 3, 2026: 3 purchases and 6 sales by directors, officers and large shareholders. All ELV insider trades →

Does Elevance Health pay a dividend?

Yes. Its dividend yield is 1.66% at the Nov 3, 2026 close (annual dividend of $6.88 per share). The next announced ex-dividend date is Dec 4, 2026.

What sector is Elevance Health in, and which index?

Elevance Health is classified in the Healthcare sector (industry: Healthcare Plans), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

Valuation multiples: P/E, P/B, EV/EBITDA and their trapsWhy the P/E and the price-to-book in the table above cannot be compared across sectors, and what a low P/E can hide.
Value and momentum: the two that have survived bestWhat the value and momentum scores on this page actually measure, and why they are the two factors that have best survived scrutiny.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
Sales growth: the driver that gets overestimated mostWhat sits behind the growth score and the twelve-month revenue, and why it is the number people extrapolate too far most often.
Dividends and payout: high is not always goodThis company pays a dividend and its yield is in the table above: when a high figure is good news and when it is a warning.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

Company Profile: Elevance Health, Inc. (ELV)

Market and Valuation

Price & Market

52-Week Range

Volume

Valuation Multiples

Dividends

Valuation Context

Financial Statements TTM (Trailing 12 Months)

Income Statement

Margins

Per Share

Balance Sheet & Liquidity

Cash Flows

Profitability

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

Growth and Margins

Per Share

Cash Flows (TTM)

EPS Surprise History - Last 4 Quarters

Ownership Structure

Ownership Distribution

Shares & Short Interest

Governance Score (1=Best, 10=Worst)

Top Institutional Holders

Top Mutual Funds

Recent Insider Trades

Options Chain

CALLS

PUTS

Sentiment Metrics

Expected move

Elevance Health, Inc. (ELV) SEC filings: 10-K, 10-Q and 8-K

Company and Executive Profile

General Information

Key Executives

You have seen the engine room

Elevance Health, Inc. (ELV): Quantitative Analysis

Factor scores

Market data

ELV latest SEC filings

Frequently asked questions about Elevance Health (ELV)

When does Elevance Health report earnings?

What is Elevance Health's P/E ratio?

Where does Elevance Health rank on Quant500?

Have Elevance Health insiders bought or sold shares?

Does Elevance Health pay a dividend?

What sector is Elevance Health in, and which index?

What is behind these numbers